BeBetter Med
China clinical-stage biopharma -- oncology, autoimmune, metabolic disease
688759 · SSE STAR Market · China
Public Market Listing
688759SSE STAR Market
Live quotes, historical charts, and market capitalization for BeBetter Med are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
5Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | CDK4 (selective)Small molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | PI3K and HDAC (dual inhibition)Small molecule | Multiple MyelomaDiffuse Large B-Cell Lymphoma Relapsed/Refractory Diffuse Large B-Cell Lymphoma | |
| Phase 2 | EGFRSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 1/2 | Angiotensinogen (AGT) / PCSK9 (dual)RNA / oligonucleotide | Hypertension |
Upcoming events
(5 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.